New User? Sign Up | Sign In

Insider Trading - New Enterprise Associates 16 L.P.

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for New Enterprise Associates 16 L.P.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-07-22
Purchase
2019-07-24
4:51 pm
Mirum Pharmaceuticals Inc. MIRM New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
450,000 $15 $6,750,000 4,186,243
(Direct)
View
2019-06-24
Purchase
2019-06-25
4:48 pm
GENOCEA BIOSCIENCES Inc GNCA New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
2,857,142 $3.5 $9,999,997 7,225,676
(Direct)
View
2019-05-09
Purchase
2019-05-13
5:10 pm
Trevi Therapeutics Inc. TRVI New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
2,500,000 $10 $25,000,000 4,438,562
(Direct)
View
2019-05-07
Purchase
2019-05-09
6:02 pm
Regulus Therapeutics Inc. RGLS Growth Equity Opportunities V LLC
New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
1,136,704 $1.08 $1,227,640 2,052,454
(Direct)
View
2019-02-14
Purchase
2019-02-19
5:00 pm
GENOCEA BIOSCIENCES Inc GNCA New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
9,948,269 $0.4713 $4,688,619 34,948,268
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-12-24
Purchase
2019-12-26
4:57 pm
2019-12-24
2024-12-24
Regulus Therapeutics Inc. RGLS Growth Equity Opportunities V LLC
New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
9,009,000 $0.125 900,900
(Direct)
View
2019-12-24
Purchase
2019-12-26
4:57 pm
2019-12-24
N/A
Regulus Therapeutics Inc. RGLS Growth Equity Opportunities V LLC
New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
900,900 $6.66 900,900
(Direct)
View
2019-07-22
Conversion
2019-07-24
4:51 pm
N/A
N/A
Mirum Pharmaceuticals Inc. MIRM New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
3,736,243 $0 4,186,243
(Direct)
View
2019-07-22
Conversion
2019-07-24
4:51 pm
N/A
N/A
Mirum Pharmaceuticals Inc. MIRM New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
29,889,944 $0 4,186,243
(Direct)
View
2019-05-09
Conversion
2019-05-13
5:10 pm
N/A
N/A
Trevi Therapeutics Inc. TRVI New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
1,938,562 $0 4,438,562
(Direct)
View
2019-05-09
Conversion
2019-05-13
5:10 pm
N/A
N/A
Trevi Therapeutics Inc. TRVI New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
17,099,316 $0 4,438,562
(Direct)
View
2019-05-07
Purchase
2019-05-09
6:02 pm
2019-05-07
2024-05-07
Regulus Therapeutics Inc. RGLS Growth Equity Opportunities V LLC
New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
3,703,704 $0.125 2,052,454
(Direct)
View
2019-05-07
Purchase
2019-05-09
6:02 pm
2019-05-07
N/A
Regulus Therapeutics Inc. RGLS Growth Equity Opportunities V LLC
New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
256,700 $10.8 2,052,454
(Direct)
View
2019-02-14
Purchase
2019-02-19
5:00 pm
2019-02-14
2024-02-14
GENOCEA BIOSCIENCES Inc GNCA New Enterprise Associates 16 L.P.
NEA Partners 16 L.P.
NEA 16 GP LLC
10% Owner
2,487,067 $0.125 34,948,268
(Direct)
View